Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

p53 protein expression and genetic mutation in two primary cell types in pulmonary sclerosing haemangioma.

Wang Y, Dai SD, Qi FJ, Xu HT, Wang EH.

J Clin Pathol. 2008 Feb;61(2):192-6. Epub 2007 Aug 17.

PMID:
17704262
2.

[Significance of p53 protein expression and p53 gene mutation in so-called pulmonary sclerosing hemangioma].

Qi F, Zhang X, Zhang Y, Wang E.

Zhongguo Fei Ai Za Zhi. 2006 Apr 20;9(2):147-51. doi: 10.3779/j.issn.1009-3419.2006.02.10. Chinese.

3.

Frequent nuclear expression of beta-catenin protein but rare beta-catenin mutation in pulmonary sclerosing haemangioma.

Chiang PM, Yuan RH, Hsu HC, Mao TL, Hu RH, Lai PL, Jeng YM.

J Clin Pathol. 2008 Mar;61(3):268-71. Epub 2007 Aug 10.

PMID:
17693578
4.

In pulmonary sclerosing hemangioma expression of ╬▓-catenin, Axin, and C-myc differs between the two cell types.

Lin XY, Zhang D, Zhang Y, Fan CF, Dai SD, Wang EH.

Virchows Arch. 2012 Jul;461(1):59-65. doi: 10.1007/s00428-012-1247-6. Epub 2012 May 22.

PMID:
22614067
5.

p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.

Griewe GL, Dean RC, Zhang W, Young D, Sesterhenn IA, Shanmugam N, McLeod DG, Moul JW, Srivastava S.

Prostate Cancer Prostatic Dis. 2003;6(4):281-5.

PMID:
14663467
7.

p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.

Tolbert DM, Noffsinger AE, Miller MA, DeVoe GW, Stemmermann GN, Macdonald JS, Fenoglio-Preiser CM.

Mod Pathol. 1999 Jan;12(1):54-60.

PMID:
9950163
9.

Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung.

Sartori G, Bettelli S, Schirosi L, Bigiani N, Maiorana A, Cavazza A, Rossi G.

Am J Surg Pathol. 2007 Oct;31(10):1512-20.

PMID:
17895751
10.

Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.

Shimizu K, Norimatsu Y, Kobayashi TK, Sakurai M, Ogura S, Yoshizawa A, Miyamoto T, Miyake Y, Aratake Y, Sakaguchi T, Ohno E.

Ann Diagn Pathol. 2009 Apr;13(2):89-95. doi: 10.1016/j.anndiagpath.2008.12.007.

PMID:
19302956
11.

p53 abnormalities in B-cell prolymphocytic leukemia.

Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ, Catovsky D.

Blood. 1997 Mar 15;89(6):2015-23.

12.

The relationship between the gene mutation of p53 and the protein expression of p53 and Ki-67 in non-Hodgkin's lymphomas.

Kuze T, Nakamura N, Hashimoto Y, Hojo H, Abe M, Wakasa H.

Pathol Int. 1996 Feb;46(2):130-6.

PMID:
10846560
13.

Expression and significance of stem cell markers in pulmonary sclerosing haemangioma.

Lin XY, Fan CF, Dong XJ, Yu JH, Dai SD, Wang EH.

Histopathology. 2012 Aug;61(2):178-85. doi: 10.1111/j.1365-2559.2011.04088.x. Epub 2012 Jun 13.

PMID:
22691172
14.

p53 protein overexpression and gene mutation in mixed M├╝llerian tumors of the uterus.

Soong R, Knowles S, Hammond IG, Michael C, Iacopetta BJ.

Cancer Detect Prev. 1999;23(1):8-12.

PMID:
9892985
15.

Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.

Keohavong P, Gao WM, Zheng KC, Mady H, Lan Q, Melhem M, Mumford J.

Anal Biochem. 2004 Jan 1;324(1):92-9.

PMID:
14654050
16.

High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.

Anzola M, Saiz A, Cuevas N, Lopez-Martinez M, Martinez de Pancorbo MA, Burgos JJ.

J Viral Hepat. 2004 Nov;11(6):502-10.

PMID:
15500550
17.

Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas.

Petri BJ, Speel EJ, Korpershoek E, Claessen SM, van Nederveen FH, Giesen V, Dannenberg H, van der Harst E, Dinjens WN, de Krijger RR.

Mod Pathol. 2008 Apr;21(4):407-13. doi: 10.1038/modpathol.3801013. Epub 2008 Jan 25.

18.

Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes.

Gong L, Ren KX, Li YH, Liu XY, Zhang WD, Yao L, Zhu SJ, Han XJ, Zhang L, Lan M, Zhang W.

Med Oncol. 2011 Sep;28(3):913-8. doi: 10.1007/s12032-010-9539-7. Epub 2010 Apr 27.

PMID:
20422318
19.

Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations?

Franchi A, Massi D, Gallo O, Santucci M, Porfirio B.

Clin Exp Dermatol. 2006 Nov;31(6):793-8. Epub 2006 Jul 4.

PMID:
16824052
20.

Significance of p53 expression in immature teratomas.

Charoenkwan P, Senger C, Weitzman S, Sexsmith E, Sherman CG, Malkin D, Thorner PS.

Pediatr Dev Pathol. 2002 Sep-Oct;5(5):499-507. Epub 2002 Sep 4.

PMID:
12202994

Supplemental Content

Support Center